The interaction of cetuximab with chemotherapeutic agents in colon cancer
Cetuximab is a monoclonal antibody targeting the epidermal growth factor receptor (EGFR) and is used for the treatment of metastatic colorectal cancer (mCRC) as monotherapy or in combination with chemotherapy. Recent clinical trials have shown little benefit in combining cetuximab with oxaliplatin i...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.634613 |